Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CBLI

Cleveland BioLabs (CBLI) Stock Price, News & Analysis

Cleveland BioLabs logo

About Cleveland BioLabs Stock (NASDAQ:CBLI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$2.20
$4.34
52-Week Range
N/A
Volume
3,208 shs
Average Volume
271,922 shs
Market Capitalization
$5 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CBLI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cleveland BioLabs and its competitors with MarketBeat's FREE daily newsletter.

CBLI Stock News Headlines

Cleveland Construction News
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Best Hospitals in Cleveland, OH
Cleveland Clinic Rehabilitation Hospital
Getting Around Cleveland
See More Headlines

CBLI Stock Analysis - Frequently Asked Questions

Cleveland BioLabs, Inc. (NASDAQ:CBLI) issued its quarterly earnings data on Friday, May, 15th. The biotechnology company reported ($0.05) earnings per share (EPS) for the quarter. The biotechnology company had revenue of $0.16 million for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cleveland BioLabs investors own include iBio (IBIO), Inovio Pharmaceuticals (INO), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Dynavax Technologies (DVAX), Novavax (NVAX) and BioCryst Pharmaceuticals (BCRX).

Company Calendar

Last Earnings
5/15/2020
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CBLI
CIK
1318641
Fax
N/A
Employees
4
Year Founded
2003

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.40 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-32.84%
Return on Assets
-31.29%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
45.93
Quick Ratio
45.93

Sales & Book Value

Annual Sales
$260 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.87 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
15,479,000
Free Float
N/A
Market Cap
$5 thousand
Optionable
Not Optionable
Beta
0.70

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:CBLI) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners